Serina Therapeutics Earnings Estimates, EPS & Revenue | AMEX:SER

Comments

Serina Therapeutics Inc Earnings Estimates

SERAMEX

Trade with Public

$1.93

-0.03-1.53%

At close: Apr 13, 5:00 PM EST

$1.92

-0.0364-1.86%

Pre-Market: 8:13 AM EST

Overview NewsEarningsAnalyst Ratings Insider Trades Short Interest Stock Report

Serina Therapeutics Earnings Estimates, EPS & Revenue | AMEX:SER

Serina Therapeutics (SER) is scheduled to report Q1 earnings on May 7, 2026. Analysts estimate EPS of $-0.44 and quarterly revenue of N/A.

In the most recent quarter (Q4), Serina Therapeutics reported EPS of $-0.31, beating estimates of $-0.47 by 0.34%. Revenue came in at $0.00, meeting the estimate of $0.00 by 0.00%.

Serina Therapeutics has beaten EPS estimates in 2 consecutive quarters.

Over the last 3 quarters, Serina Therapeutics has averaged an EPS surprise of 0.37% and a revenue surprise of 0.00%.

Earnings Date

May 7

EPS Estimate

$-0.440

Quarterly Revenue Estimate

–

Annual Revenue
(as of Dec 31)

–

Serina Therapeutics Earnings History

Analyze the earnings history of Serina Therapeutics using advanced sorting and filters.

Loading calendar...

Serina Therapeutics (SER) Earnings Per Share

The chart below shows Serina Therapeutics's reported EPS compared to analyst estimates over recent quarters.

Serina Therapeutics (SER) Revenue

The chart below shows Serina Therapeutics's reported revenue compared to analyst estimates over recent quarters.

FAQ

When is Serina Therapeutics (AMEX:SER) reporting earnings?

Serina Therapeutics (SER) is scheduled to report earnings on May 7, 2026. The last reported earnings were for reported on March 25, 2026 for Q4.

What were the latest earnings per share (EPS) for Serina Therapeutics (AMEX:SER)?

The Actual EPS was $-0.31, which beat the estimate of $-0.47.

What were Serina Therapeutics’s (AMEX:SER) revenues?

The Actual Revenue was $0.00, which hit the estimate of $0.00.

People Also Watch

Outlook Therapeutics Inc

NNVC

Barinthus Biotherapeutics PLC

NASDAQ:BRNS

$0.56

-8.29%

Vistagen Therapeutics Inc

NASDAQ:VTGN

$0.63

4.76%

Tevogen Bio Holdings Inc

Serina Therapeutics Earnings Estimates, EPS & Revenue | AMEX:SER

Serina Therapeutics (SER) is scheduled to report Q1 earnings on May 7, 2026. Analysts estimate EPS of $-0.44 and quarterly revenue of N/A.

In the most recent quarter (Q4), Serina Therapeutics reported EPS of $-0.31, beating estimates of $-0.47 by 0.34%. Revenue came in at $0.00, meeting the estimate of $0.00 by 0.00%.

Serina Therapeutics has beaten EPS estimates in 2 consecutive quarters.

Over the last 3 quarters, Serina Therapeutics has averaged an EPS surprise of 0.37% and a revenue surprise of 0.00%.

Earnings Date

May 7

EPS Estimate

$-0.440

Quarterly Revenue Estimate

–

Annual Revenue
(as of Dec 31)

–